N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine

C70H68N18O5 — CID 135313257

IUPACN-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
SMILESCN(C)C(=O)c1ccccc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.Cc1ccncc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.O=C(NC1CC1)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1
InChIInChI=1S/C25H24N6O2.C24H24N6O2.C21H20N6O/c32-25(28-18-5-6-18)17-3-1-16(2-4-17)20-15-22(31-11-13-33-14-12-31)29-23-19(20)7-9-26-24(23)21-8-10-27-30-21;1-29(2)24(31)18-6-4-3-5-16(18)19-15-21(30-11-13-32-14-12-30)27-22-17(19)7-9-25-23(22)20-8-10-26-28-20;1-14-2-5-22-13-17(14)16-12-19(27-8-10-28-11-9-27)25-20-15(16)3-6-23-21(20)18-4-7-24-26-18/h1-4,7-10,15,18H,5-6,11-14H2,(H,27,30)(H,28,32);3-10,15H,11-14H2,1-2H3,(H,26,28);2-7,12-13H,8-11H2,1H3,(H,24,26)
InChIKeyCYQJLTPHQGEDMC-UHFFFAOYSA-N
MW1241.43 g/mol
LogP9.87
Rot. Bonds12

About N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine

N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine (PubChem CID 135313257) has the molecular formula C70H68N18O5 and a molecular weight of 1241.43 g/mol. Its IUPAC name is N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine.

Molecular Properties

Compound NameN-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
PubChem CID135313257
Molecular FormulaC70H68N18O5
Molecular Weight1241.43 g/mol
Exact Mass1240.56
IUPAC NameN-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
SMILESCN(C)C(=O)c1ccccc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.Cc1ccncc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.O=C(NC1CC1)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1
InChIInChI=1S/C25H24N6O2.C24H24N6O2.C21H20N6O/c32-25(28-18-5-6-18)17-3-1-16(2-4-17)20-15-22(31-11-13-33-14-12-31)29-23-19(20)7-9-26-24(23)21-8-10-27-30-21;1-29(2)24(31)18-6-4-3-5-16(18)19-15-21(30-11-13-32-14-12-30)27-22-17(19)7-9-25-23(22)20-8-10-26-28-20;1-14-2-5-22-13-17(14)16-12-19(27-8-10-28-11-9-27)25-20-15(16)3-6-23-21(20)18-4-7-24-26-18/h1-4,7-10,15,18H,5-6,11-14H2,(H,27,30)(H,28,32);3-10,15H,11-14H2,1-2H3,(H,26,28);2-7,12-13H,8-11H2,1H3,(H,24,26)
InChIKeyCYQJLTPHQGEDMC-UHFFFAOYSA-N
XLogP9.87
TPSA263.09 Ų
H-Bond Donors4
H-Bond Acceptors18
Rotatable Bonds12
Heavy Atoms93
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001241.43
LogP ≤ 59.87
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1018

Analyze N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
The IUPAC name of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine (CID 135313257) is N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine.
What is the SMILES notation for N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
The canonical SMILES for N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine is CN(C)C(=O)c1ccccc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.Cc1ccncc1-c1cc(N2CCOCC2)nc2c(-c3ccn[nH]3)nccc12.O=C(NC1CC1)c1ccc(-c2cc(N3CCOCC3)nc3c(-c4ccn[nH]4)nccc23)cc1.
What is the InChIKey of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
The InChIKey is CYQJLTPHQGEDMC-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H24N6O2.C24H24N6O2.C21H20N6O/c32-25(28-18-5-6-18)17-3-1-16(2-4-17)20-15-22(31-11-13-33-14-12-31)29-23-19(20)7-9-26-24(23)21-8-10-27-30-21;1-29(2)24(31)18-6-4-3-5-16(18)19-15-21(30-11-13-32-14-12-30)27-22-17(19)7-9-25-23(22)20-8-10-26-28-20;1-14-2-5-22-13-17(14)16-12-19(27-8-10-28-11-9-27)25-20-15(16)3-6-23-21(20)18-4-7-24-26-18/h1-4,7-10,15,18H,5-6,11-14H2,(H,27,30)(H,28,32);3-10,15H,11-14H2,1-2H3,(H,26,28);2-7,12-13H,8-11H2,1H3,(H,24,26).
What are the key properties of N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine?
N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine has a molecular weight of 1241.43 g/mol, XLogP of 9.87, 12 rotatable bonds, 4 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-4-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;N,N-dimethyl-2-[2-morpholin-4-yl-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-4-yl]benzamide;4-[4-(4-methyl-3-pyridinyl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine is sourced from PubChem (CID 135313257), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).